Can-Fite BioPharma Ltd. Payments of Stock Issuance Costs
Can-Fite BioPharma Ltd. (CANF) reported Payments of Stock Issuance Costs of $452.00 thousand for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Cash Flow › Financing Activities
us-gaap:PaymentsOfStockIssuanceCosts · last filed 2026-03-26
| Period end | Payments of Stock Issuance Costs | Payments of Stock Issuance Costs 0 month | Payments of Stock Issuance Costs 1 month | Payments of Stock Issuance Costs 6 month | Payments of Stock Issuance Costs 12 month |
|---|---|---|---|---|---|
| 2025-12-31 | $452.00K 20-F · filed 2026-03-26 | ||||
| 2025-06-30 | $452.00K 6-K · filed 2025-08-28 | ||||
| 2024-12-31 | $512.00K 20-F · filed 2025-04-14 | ||||
| 2023-12-31 | $973.00K 20-F · filed 2025-04-14 | ||||
| 2023-06-30 | $978.00K 6-K · filed 2024-08-29 | ||||
| 2020-01-09 | $0.10 20-F · filed 2023-03-30 | ||||
| 2019-05-22 | $540.00K 20-F · filed 2022-03-24 | ||||
| 2019-04-04 | $414.00K 20-F · filed 2022-03-24 | ||||
| 2019-01-18 | $428.00K 20-F · filed 2022-03-24 |